Nippon Kayaku Co 4272.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4272.T. It has been listed since 16 May 1949. In the fiscal year to 31 March 2026, it reported revenue of ¥241.85bn and net income of ¥24.64bn. At that date it held total assets of ¥398.74bn and shareholders' equity of ¥279.00bn.

Nippon Kayaku Co., Ltd. engages in the manufacture and sale of chemicals. The company is headquartered in Chiyoda-Ku, Tokyo-To. The firm has three business segments. The Functional Chemical segment manufactures and sells functional materials, such as epoxy resin, ultraviolet curable resin and high-performance chemicals; pigment materials, including functional dyes, pigment for inkjet printers and others; catalysts, such as catalysts for acrylic and methacrylic acid manufacturing, as well as coloring materials, such as dyes and special coloring materials for nonfibrous products, among others. The Pharmaceutical segment supplies pharmaceutical products, medical intermediates and diagnostic medicines, among others. The Safety Systems segment provides inflators for airbags and micro gas generators for seatbelt pretensioners. The firm is also engaged in the manufacture and sale of agricultural chemicals.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Atsuhiro WakumotoPresident, Executive President, Representative Director, since 2012¥111.0m
• Mr. Yoshitsugu IshidaExecutive Vice President, Representative Director, since 2016
• Mr. Shinji InoueManaging Executive Officer, Director, since 2020
• Mr. Shigeyuki KawamuraManaging Executive Officer, Chief Director of Safety Systems Business, Director, since 2020
• Mr. Hiroshi ShimadaManaging Executive Officer, Director of Pharmaceutical Business, Director, since 2021
• Mr. Makoto TakedaManaging Executive Officer, Director, since 2022
• Mr. Yoshiki AkataniSenior Executive Officer
• Mr. Yasuhito KatoSenior Executive Officer
• Mr. Shinya IkedaExecutive Officer, Chief Director of Sales in Pharmaceutical Regional Business Unit in Life Sciences Business
• Mr. Tsutomu KawamuraExecutive Officer, Director of Accounting
• Ms. Masako AonoExecutive Officer, Director of Business Planning
• Mr. Takumi FujitaExecutive Officer, General Manager of Subsidiary

Overall

81

Environment

99

Social

93

Governance

51

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.